A Look at Charles River Laboratories International Inc (CRL) After 7.1% Gain -- GF Value $194.24 vs Price $310.77
gurufocus.com · 2026-10-05
On October 05, 2026, Charles River Laboratories International Inc (CRL) shares experienced a notable rise of 7.1%, reaching a price of $310.77. This price is si
TickrTrends take: Charles River Laboratories trades at approximately 160% of its GF Value estimate, reflecting a significant premium to the valuation model's assessment. The Healthcare sector stock has appreciated substantially, and TickrTrends currently considers it overvalued at these levels. Investors focused on valuation metrics should monitor whether the stock's price moves closer to fundamental value or whether the company's earnings growth accelerates enough to justify the current premium.
Read the full story at gurufocus.com →
Is CRL undervalued? See TickrTrends' fair value analysis →